Zeolites as Carriers of Antitumor Ribonuclease Binase.
binase
chabazite
clinoptilolite
cytotoxic RNAse
immobilization
natrolite
zeolites
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2019
2019
Historique:
received:
27
12
2018
accepted:
08
04
2019
entrez:
28
5
2019
pubmed:
28
5
2019
medline:
28
5
2019
Statut:
epublish
Résumé
Natural and synthetic zeolites have many applications in biomedicine and nutrition. Due to its properties, zeolites can absorb therapeutically active proteins and release them under physiological conditions. In this study we tested the clinoptilolite, chabazite, and natrolite ability to be loaded by antitumor ribonuclease binase and the cytotoxicity of the obtained complexes. We found the optimal conditions for binase loading into zeolites and established the dynamic of its release. Cytotoxic effects of zeolite-binase complexes toward colorectal cancer Caco2 cells were characterized after 24 and 48 h of incubation with cells using MTT-test. Zeolites were toxic by itselfs and reduced cells viability by 30% (clinoptilolite), 40% (chabazite), and 70% (natrolite) after 48 h of incubation. Binase complexes with clinoptilolite as well as chabazite always demonstrated enhanced toxicity (up to 57 and 60% for clinoptilolite and chabazite, respectively) in comparison with binase and zeolites separately. Our results contribute to the perspective development of binase-based complexes for therapy of colorectal cancer for or the treatment of malignant skin neoplasms where the complexes can be used in pasty form.
Identifiants
pubmed: 31130858
doi: 10.3389/fphar.2019.00442
pmc: PMC6509225
doi:
Types de publication
Journal Article
Langues
eng
Pagination
442Références
Klin Lab Diagn. 1999 May;(5):14-6
pubmed: 10399432
FEBS Open Bio. 2016 Jan 19;6(1):24-32
pubmed: 27047739
Cell Cycle. 2010 Jul 1;9(13):2674-8
pubmed: 20581458
Cell Cycle. 2013 Jul 1;12(13):2120-31
pubmed: 23759588
Biochimie. 2014 Jun;101:256-9
pubmed: 24565811
Cell Cycle. 2015;14(7):931-2
pubmed: 25714843
Biochimie. 2013 Jun;95(6):1344-9
pubmed: 23499289
Nat Commun. 2015 Oct 20;6:8633
pubmed: 26482337
Biochim Biophys Acta. 2014 Apr;1845(2):232-47
pubmed: 24491449
Toxicon. 2013 Jul;69:219-26
pubmed: 23567038
FEBS Lett. 2003 Apr 10;540(1-3):15-20
pubmed: 12681476
J Environ Manage. 2016 Feb 1;167:147-55
pubmed: 26686066
J Int Soc Sports Nutr. 2015 Oct 20;12:40
pubmed: 26500463
Biomed Khim. 2016 Mar;62(3):279-82
pubmed: 27420619
J Clin Biochem Nutr. 2012 May;50(3):195-8
pubmed: 22573920
IET Nanobiotechnol. 2017 Aug;11(5):538-545
pubmed: 28745286
Toxicology. 2001 Jan 2;156(2-3):101-7
pubmed: 11164612
Nanomedicine. 2014 Jan;10(1):197-205
pubmed: 23916887
Front Pharmacol. 2017 Sep 12;8:631
pubmed: 28955235
Biochim Biophys Acta. 2016 Jul;1863(7 Pt A):1559-67
pubmed: 27066977
Anticancer Res. 2003 Mar-Apr;23(2B):1589-95
pubmed: 12820427
Microbiol Res. 2017 Jan;195:24-30
pubmed: 28024523
Toxicology. 1997 Jun 6;120(1):55-63
pubmed: 9160109
Int J Toxicol. 2003;22 Suppl 1:37-102
pubmed: 12851164
Water Res. 2016 May 15;95:134-41
pubmed: 26990838
Nutr Hosp. 2015 Aug 01;32(2):573-81
pubmed: 26268084
Cell Cycle. 2011 Dec 1;10(23):4090-7
pubmed: 22101339
Nutrients. 2017 May 06;9(5):
pubmed: 28481231
Protein Sci. 2002 Oct;11(10):2522-5
pubmed: 12237473
Mediators Inflamm. 2017;2017:4029641
pubmed: 28804220
J Anim Sci Technol. 2016 Jun 22;58:24
pubmed: 27413536
Adv Ther. 2004 Mar-Apr;21(2):135-47
pubmed: 15310086